Missing/wrong data?
Log in to edit
A phase 1 study of lucatumumab, a fully human anti‐CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma
scientific article published on August 4, 2012
Author/s
author: John Rediske, Edward A. Stadtmauer
Work details
Publication date
August 4, 2012
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.